Case Report
Ms. U is a 39-year-old Japanese lady, who had a strong family predisposition to rheumatic conditions. Her son had cutaneous polyarthritis nodosa (PAN), diagnosed at the age of 11 and her daughter had Kawasaki disease at one year old. Ms. U was told to have colitis as an infant and have hepatitis B and C during prenatal check-up. She had suffered from recurrent mild episodes of aphthous ulcers for years but otherwise, she enjoyed good health.
In December 2013, Ms. U complained of bilateral foot pain and consulted a private rheumatologist. Disease However, sural nerve biopsy and tibialis anterior muscle biopsy detected no significant pathologies. In view of the presenting symptoms and the imaging findings, differential diagnosis including inflammatory myositis (with small foot muscles involvement) and limited PAN were proposed. Prednisolone 40 mg daily plus methotrexate were given for her small muscles myositis. Her feet pain improved though the swelling persisted, ESR and CRP decreased to 90 mm/hr and 20 mg/L respectively.
Four months later, pain and swelling developed around the right first and second metacarpophalangeal joints ( Figure 3a ) and recurrent oral ulcers. Vasculitic skin rash and tender subcutaneous nodules were noted over her right shin and foot (Figure 3b, c) . She complained of frequent loose bowel opening for one month. Skin biopsy showed septa expanded by inflammatory infiltrates composed of lymphocytes and histiocytes in the subcutis. A few small arteries, arterioles and venules in the septa of subcutis showed signs of vasculitis featuring infiltration of the vessel wall by inflammatory cells (predominately lymphocytes and histiocytes with occasional neutrophils) Figure 2 . (a)(b) Maximum intensity projection (MIP) images of MR arteriography showed normal arteries from abdominal aorta down to feet. Fluffy nodular enhancement was seen within the muscle compartments at bilateral calves, lower legs and feet. T2 with fat-saturation sagittal (c), coronal (d), and axial (e) images of the right foot and ankle showed myositis in extensor digitorum longus, tibialis posterior, flexor hallucis longus, and small muscles at dorsal and plantar sides of the foot. accompanied by nuclear dusts and fibrinoid necrosis in the blood vessel wall. No granuloma or granulomatous vasculitis was seen. Colonoscopy showed active colitis over caecum, sigmoid colon and rectum with multiple ulcerations, biopsy showed no feature of infection or malignancy. Follow up MRI feet showed persistent myositis with patchy edema and post-contrast enhancement within muscle bellies of flexor and extensor muscles (Figure 4) . With the presence of vasculitis involving arterioles and venules in the subcutis, the clinical history of recurrent oral ulcers, multiple colonic ulcerations and subsequent positive HLA B51 status, the diagnosis of BD was made.
The treatment was switched to prednisolone 50mg daily with azathioprine. Her symptoms recurred once prednisolone was tapered down, with raised ESR and CRP (Figure 5a ). MRI bilateral lower limbs ( Figure 6 ) in June 2016 showed partial resolution of myositis in bilateral legs, and disappearance of myositis changes in bilateral feet, but skin and subcutaneous edema persisted. Cyclosporin was added on top of azathioprine, but her myalgia recurred and follow up colonoscopy still showed mild caecal ulcer. In view of the recurring debilitating symptoms and refractory myositis, adalimumab 40 mg every two weeks was commenced in October 2016. 
Discussion
Behçet's disease was first described by the Turkish dermatologist Hulusi Behçet in 1937. It is a multisystem inflammatory disease characterized by mucocutaneous lesions and vasculitis. Turkey has the highest prevalence of BD, with 420 cases per 100,000. The prevalence in Japan, Korea, China, Iran, and Saudi Arabia ranges from 13.5-22 initially diagnosed as incomplete BD with oral ulcers and positive pathergy tests only. He developed recurrent right calf myositis and later, leukocytoclastic vasculitis. BD was confirmed six years after initial symptoms. Another was a 16 years old Japanese girl presented with intermittent painful swelling over bilateral calves for seven years. 15 MRI confirmed myositis over her bilateral gastrocnemius and soleus muscles. Later, she noted recurrent oral and genital ulcers. Her myositis was not controlled optimally and relapsed once steroid was tapered down, like in our case. Whole BD characteristics manifested sequentially over 6 years.
Patients with BD myositis usually present with myalgia or muscle weakness typically involving the lower cases per 100,000. Although typical features include recurrent oral or genital ulcerations, eye, cutaneous or vascular lesions, myositis in BD has been reported as a rare presentation. Taarit et al. had identified two myositis among 309 BD cases. 1 Eye manifestations were found to be less frequent in children type, while atypical presentation like myositis appeared to be more common among them. 13, 15 After the first index case of Behçet's myositis 2 reported by Charles R et al. in 1980, more cases were noted in Turkey, 3 America 4 and Italy. 5 Table 1 summarizes the 18 Behçet's myositis reports published in English literature (including our case). Majority of them were adults and four were children. [12] [13] [14] [15] Among the pediatric cases, two resembled our patient: one was a 12 years old Israeli boy, who was extremities. 8, 15 They are usually focal (localized to single muscle group) and the disease activity is mostly mild and short-lasting, though recurrence is common. 10, 13, 14, 15, 16, 17 Making the diagnosis of BD usually rests on clinical ground, but sometimes can be difficult with an atypical presenting feature such as myositis. In Japanese series, 90% BD cases do not fulfill the BD international criteria at their initial presentations, the manifestations can occur one by one over several years. 9 A very important differential diagnosis in our case is PAN in view of a positive family history and its typical association with hepatitis B. Our patient fulfilled the International Criteria for Bechet's Disease (ICBD) two years after she presented with feet pain, and subsequent positivity of HLA typing for B51 further provide more evidence to confirm the diagnosis of BD. Evidence from meta-analysis supports that this allele being a primary and causal risk determinant for BD. 18 In a suspected case of BD myositis, MRI is helpful to localize the affected muscle group(s) and to guide biopsy when pathological confirmation is needed. Typical MRI findings of BD myositis include increased signal intensity on T2-weighted or STIR images with contrast enhancement in certain muscle area. Patterns of multiple nodular, patchy or diffuse intramuscular T2-weighted signal changes, and a rarer form of focal necrotizing myositis, have been described. 10, 19, 20 Apart from intramuscular signal changes, MRI may demonstrate myofascial enhancement and T2 high-intensity edema of subcutaneous fat layer in vicinity to BD myositis. 19 Distinguishing infectious myositis (with or without fasciitis) from Behçet's myositis, or focal myonecrosis from intramuscular microabscess, can be difficult solely by imaging. However, multiplicity and bilaterality of skeletal muscle involvement may help to insure the diagnosis of myositis in patients with Bechet's disease. 19 Muscle biopsy can further help to establish the diagnosis of myositis. Typical histological findings include granulocytic-monocytic necrotizing reaction, due to neutrophil-mediated vasculitis in the acute phase, while in the chronic phase, lymphocytic infiltration predominates in muscle specimen. 8 Circulating immune complexes and neutrophil-mediated vascular damage was the proposed mechanism for BD myositis. However, in long-standing BD cases with new myositis development, muscle biopsy might not be necessary and MRI is the preferred diagnostic modality instead. 13, 15 Most patients suffering from Behçet's myositis had favorable outcomes, and some would even resolve spontaneously without therapy. Majority responded well to a short course of corticosteroid and/or Colchicine (Table 1) . However, Ms. U had a refractory myositis leading to functional impairment, despite the combination of steroid and immunosuppressants. TNFi were well proven to be effective in treating BD with ocular, intestinal or mucocutaneous involvement but treatment for Behçet's myositis was not reported. To the best of our knowledge, this is the first reported case of BD myositis that was successfully controlled with TNFi therapy.
